Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Labelled Randomized Multi-center Study of COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Incidence of Contrast Induced Nephropathy

NCT00497328 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT00497328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00497328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Labelled Randomized Multi-center Study of COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Incidence of Contrast Induced Nephropathy
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2013
Enrollment
477 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy